Cell Therapy Development
The first 44-marker high-resolution mass cytometry panels dedicated to accelerating development of T and NK cell therapies.
Source identification
Select ideal donor and source material based with profiling of over 1T cellular marker combinations
Process optimization
Increase yield, shorten turnaround, and optimize final cellular product with data-driven insights at every stage of the process
Clinical profiling
Track and profile cell therapy product in vivo to identify early phenotypic markers of response
Let data drive your development pipeline
Improve cell therapy development and manufacturing with high-resolution data profiling how each stage of therapeutic development impacts function of final product
Deep phenotypic profiling of T cell subsets and states
Profile engineered T and CAR T cell therapies with our specially designed 35-marker T cell panel. Phenotypically characterize all major T cell subsets across markers of activation, maturation, and immune checkpoints. Includes up to 9 additional open channels to track product-specific markers of interest
Deep profiling of NK cell receptor expression
Teiko is developing the first 44-marker mass cytometry panel focused entirely on NK cell receptor profiling for cell therapy development. Profile markers of NK maturation and activation plus over 20 activating and inhibitory receptors per cell. Panel includes up to 5 open channels to track product-specific markers of interest.